Country (costing year) | Location (settings) | Population protected | Larvicide (potency) | Product (formulation) | Targeting strategy | Average annual costs | Cost PPPY | References |
---|---|---|---|---|---|---|---|---|
Tanzania (2006) | Dar es Salaam (urban) | 592338 | Bti (200 ITU/mg) | VectoBac® (CG) | None | 559476.3d | 0.94 | [94] |
Kenya (2006) | Vihiga (rural) | 609324 | Bti (200 ITU/mg) | VectoBac® (CG) | Spatial and temporala | 916908d | 1.50 | [94] |
Kenya (2006) | Vihiga (rural) | 609324 | Bti (3000 ITU/mg) | VectoBac® (WDG) | Spatial and temporala | 480735d | 0.79 | [94] |
Kenya (2006) | Mbita (rural) | 55558 | Bti (200 ITU/mg) | VectoBac® (CG) | Spatialb | 138866d | 2.50 | [94] |
Kenya (2006) | Mbita (rural) | 55558 | Bti (3000 ITU/mg) | VectoBac® (WDG) | Spatialb | 107669d | 1.94 | [94] |
Burkina Faso (2013) | Nouna (rural) | 156000 | Bti (3000 ITU/mg) | VectoBac® (WDG) | None | 163038 | 1.05 | [52] |
Burkina Faso (2013) | Nouna (rural) | 156000 | Bti (3000 ITU/mg) | VectoBac® (WDG) | Spatialc | 120239 | 0.77 | [52] |
Tanzania (2014) | Mvomero (rural) | 37083 | Bti (not stated) | VectoBac® (CG) | None | 53782.53 | 1.44 | [93] |
Tanzania (2012) | Dar es Salaam (urban) | 6875784 | Bti (200 ITU/mg) | VectoBac® (CG) | None | 5111234 | 0.87 | [92] |
Kenya (2005) | Mbita (rural) | 8000 | Bti (200 and3000) + Bs (50 and 650 ITU/mg) | VectoBac® (WDG & CG) + VectoLex® (WDG & CG) | Spatialb | 6773–7026 | 0.85–0.89 | [49] |
Burkina Faso (1999) | Bobo-Dioulasso (urban) | 19245 | Bs (not stated) | VectoLex® (WDG); Spherimos (FC); Locally made (SRG) | None | 8400e | 0.44 | [95] |
Burkina Faso (1999) | Ouagadougou (urban) | 17776 | Bs (not stated) | VectoLex® (WDG), Spherimos (FC), Locally made (SRG) | None | 8400e | 0.47 | [95] |